Silicosis
17
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (17)
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
Reducing Silica Exposure Among Brick Kiln Workers in Nepal
Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania
Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
Silicosis Treatment, Action, Screening and Surveillance in Rwanda Trials
The SHIELD Study-silicosis
The SHIELD Whole Lung Lavage Study
Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
Specialized Center of Research in Occupational and Immunologic Lung Disease
Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)